bumetanide has been researched along with Cystic Periventricular Leukomalacia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We hypothesized that NKCC1 is highly expressed on oligodendrocytes (OLs) and increases vulnerability to hypoxia-ischemia (HI) mediated white matter injury, and that the NKCC1 inhibitor bumetanide would be protective in a rodent PVL model." | 3.81 | Chloride cotransporter NKCC1 inhibitor bumetanide protects against white matter injury in a rodent model of periventricular leukomalacia. ( Hu, MY; Jackson, MC; Jantzie, LL; Jensen, FE; Maxwell, JR; Park, HK; Yu, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jantzie, LL | 1 |
| Hu, MY | 1 |
| Park, HK | 1 |
| Jackson, MC | 1 |
| Yu, J | 1 |
| Maxwell, JR | 1 |
| Jensen, FE | 1 |
1 other study available for bumetanide and Cystic Periventricular Leukomalacia
| Article | Year |
|---|---|
Chloride cotransporter NKCC1 inhibitor bumetanide protects against white matter injury in a rodent model of periventricular leukomalacia.
Topics: Animals; Bumetanide; Cerebral Cortex; Disease Models, Animal; Gene Expression Regulation; Hypoxia; I | 2015 |